SCHEMBL20766604

SCHEMBL20766604

NC(=O)C[C@@H](C(=O)O)N1Cc2c(O)cccc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 3/20 0.42
STAT3 P40763 1/20 0.40
CRBN Q96SW2 1/20 0.38
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
XIAP P98170 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SDCBP O00560 2/20 0.36
SDC2 P34741 2/20 0.36
GAA P10253 1/20 0.36
POLB P06746 3/20 0.36
TNF P01375 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766605 1.00 ALOX15 (0.45) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL2250406 0.88 MEN1 (0.48) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7679763 0.87 ALOX15 (0.45) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7680330 0.86 MAPT (0.44) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL20766677 0.85 NPC1 (0.48) ALOX15MAPTSMN1; SMN2KDM4ECRBN
SCHEMBL20766676 0.85 NPC1 (0.48) ALOX15MAPTSMN1; SMN2KDM4ECRBN
SCHEMBL7679480 0.85 ALOX15 (0.43) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL7671077 0.84 ALOX15 (0.43) ALOX15MAPTSMN1; SMN2KDM4ESTAT3
SCHEMBL28403557 0.83 TNF (0.46) ALOX15MAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL7674304 0.83 MAPT (0.42) ALOX15MAPTSMN1; SMN2KDM4ESTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927104-B2 Ether compounds and uses thereof BIOTHERYX, INC. (US) 2021-02-23 US disclosed
US-20200231582-A1 ETHER COMPOUNDS AND USES THEREOF BIOTHERYX, INC. 2020-07-23 US disclosed
EP-3672955-A1 ETHER COMPOUNDS AND USES THEREOF Biotheryx Inc. (US) 2020-07-01 EP disclosed
CN-111247138-A Ether compound and use thereof 拜欧赛里克斯公司 2020-06-05 CN disclosed
WO-2019040274-A1 ETHER COMPOUNDS AND USES THEREOF BIOTHERYX, INC. (US) 2019-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927104-B2 Ether compounds and uses thereof EPCAM, ICAM1, SELE ALOX15 421/4885MAPT 2110/4885SMN1; SMN2 1151/4885
US-20200231582-A1 ETHER COMPOUNDS AND USES THEREOF EPCAM, ICAM1, SELE ALOX15 421/4885MAPT 2110/4885SMN1; SMN2 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.